For the past 18 months, ResMed Chief Executive Mick Farrell has been publicly outspoken in urging that medical devices get priority access to semiconductors amid global chip shortages coming out of ...
SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ...
The incoming AdvaMed chair talked about updates to Resmed’s products and how the company is handling competitive dynamics and ...
ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...
SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD) today introduced the QuietAir diffuser vent elbow, for its latest continuous positive airway pressure (CPAP) full face masks: AirFit F20 with ...
ResMed Inc . (NYSE:RMD) reported its Q2 FY2025 earnings, surpassing analyst expectations with an earnings per share (EPS) of $2.43, against a forecast of $2.32. The company also exceeded revenue ...
Component shortages continued to curb growth potential of San Diego sleep apnea giant ResMed— though it looks like the lingering supply chain woes could begin to ease heading into summer. That’s the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback